Refer Case Study 2 EVALUATE the proposal made by Charlotte Peters for the acquisition of Rediwrap India Limited by Synovia & Synovia Life…

Charlotte Peters has proposed that Synovia & Synovia Life Sciences Ltd. (S&S) acquire Rediwrap India Limited as a wholly owned subsidiary to strengthen its supply chain and support the proposed implementation of a pull-based inventory management system. The proposal should be evaluated by considering both its strategic benefits and the associated risks. Advantages of the Acquisition Greater supply chain control and responsiveness - Rediwrap currently supplies nearly 90% of its production to S&S, with an average lead time of five days from receipt of an order. However, occasional delays arise when Rediwrap prioritizes large orders from external customers. If Rediwrap becomes a wholly owned subsidiary, S&S can align production schedules with its own manufacturing requirements, thereby ensuring uninterrupted availability of packaging materials. This would improve supply chain responsiveness, particularly if the company adopts a pull-based inventory management system. Cost optimization - At present, the purchase price paid by S&S includes Rediwrap's profit margin, increasing the procurement cost of packaging materials. Following the acquisition, such external profit margins would effectively be eliminated at the group level. Although Rediwrap may continue to charge internal transfer prices for operational purposes, inter-company profits would be eliminated on consolidation, thereby reducing the overall cost to the group and improving operational efficiency. Improved quality control and operational integration - Packaging plays a critical role in preserving the quality, safety, and effectiveness of pharmaceutical products. Complete ownership would enable S&S to exercise greater control over Rediwrap's manufacturing processes, quality standards, production planning, and delivery schedules. Better coordination between the two entities can strengthen quality assurance and improve overall operational integration. Disadvantages / Risks of the Acquisition Risk of operational inefficiencies - At present, Rediwrap competes in the open market and must continuously control costs and improve efficiency to remain competitive. Once it becomes a captive subsidiary serving only S&S, competitive pressures may reduce, increasing the risk of managerial complacency and operational inefficiencies. Any increase in Rediwrap's cost structure would ultimately be borne by S&S, potentially increasing the cost of its finished pharmaceutical products. Accordingly, appropriate performance measurement systems and benchmarking mechanisms should be implemented to ensure that Rediwrap continues to operate efficiently despite becoming an internal supplier. Financial and capital allocation risks - The case indicates that S&S is already investing substantial financial resources towards its strategic expansion into African markets through acquisitions and investments in manufacturing facilities. Acquiring Rediwrap would require additional capital and may divert funds from these high-priority strategic initiatives. If financed through borrowings, the acquisition could increase the company's leverage and financial risk at a time when export profitability is already under pressure due to higher international trade tariffs. Therefore, the acquisition should be undertaken only after carefully evaluating its funding structure, expected returns, and impact on the company's capital structure and liquidity. Conclusion The proposed acquisition offers significant strategic advantages in terms of supply chain integration, improved responsiveness, cost optimization, and enhanced quality control, particularly if S&S proceeds with the implementation of a pull-based inventory management system. However, these benefits must be weighed against the potential risks of reduced operating efficiency at Rediwrap and the additional financial commitment required when the company is simultaneously pursuing its expansion into African markets. Accordingly, the acquisition should be undertaken only if a detailed financial and strategic appraisal demonstrates that the expected long-term benefits outweigh the associated costs and risks. Further, S&S should ensure that Rediwrap continues to operate with market-driven efficiency through appropriate performance management systems while maintaining a prudent capital structure to avoid excessive financial leverage.